Horny H P, Campbell M, Steinke B, Kaiserling E
Department of Special Histo- and Cytopathology, Eberhard-Karls University, Tübingen, Federal Republic of Germany.
Hum Pathol. 1990 Jun;21(6):648-55. doi: 10.1016/s0046-8177(96)90012-x.
Immunohistochemical investigations were performed on decalcified, paraffin-embedded iliac crest trephine biopsy specimens from 30 cases of acute myeloid leukemia (AML, as defined by the FAB classification) with antibodies against B cells (L26, 4KB5, MB1, Ki-B3), T cells (UCHL1, MT1), myeloid/histiocytic cells (anti-neutrophil elastase, MAC387, anti-S-100 protein, anti-alpha 1-antichymotrypsin, DAKO-M1), natural killer/killer cells (anti-Leu-7), and megakaryocytes (anti-factor VIII-related antigen). (1) The blast cells of all the cases reacted with from at least two to at most eight different antibodies. Each antibody reacted with blast cells in a minimum of two (maximum 30) cases. (2) MT1, Ki-B3, anti-alpha 1-antichymotrypsin anti-neutrophil elastase, anti-S-100 protein, and MAC387 stained blast cells in more than 50% of the cases; MB1, L26, UCHL1, 4KB5, and DAKO-M1 in 20% to 50% of the cases; and anti-Leu-7 and anti-factor VIII-related antigen in less than 20% of the cases. (3) In the majority of cases many T lymphocytes, a small-to-moderate number of B lymphocytes, and a few Leu-7-positive lymphoid cells were intermingled with the blast cells. In some cases, especially where only a minor proportion of the blast cells was immunostained, it was nearly impossible to distinguish the lymphocytes of the tumor's stromal reaction from small blast cells. Thus, AML exhibits a heterogeneous immunophenotype in trephine biopsy specimens. Immunohistologic diagnosis of this disease in such specimens may be extremely difficult. Since staining of the blast cells with one or more of the antibodies generally used to define B cells, T cells, or their neoplastic derivatives is not uncommon, misinterpretation as non-Hodgkin's lymphoma of high-grade malignancy could easily occur. These findings also suggest that mixed-type (hybrid) acute leukemias with coexpression of myeloid and lymphoid cell markers could be more common than generally realized.
对30例急性髓系白血病(AML,按照FAB分类定义)患者经脱钙、石蜡包埋的髂嵴环钻活检标本进行免疫组织化学研究,所用抗体针对B细胞(L26、4KB5、MB1、Ki-B3)、T细胞(UCHL1、MT1)、髓系/组织细胞(抗中性粒细胞弹性蛋白酶、MAC387、抗S-100蛋白、抗α1-抗糜蛋白酶、DAKO-M1)、自然杀伤/杀伤细胞(抗Leu-7)以及巨核细胞(抗VIII因子相关抗原)。(1)所有病例的原始细胞与至少两种至多八种不同抗体发生反应。每种抗体在至少两例(最多30例)病例中与原始细胞发生反应。(2)MT1、Ki-B3、抗α1-抗糜蛋白酶、抗中性粒细胞弹性蛋白酶、抗S-100蛋白和MAC387在超过50%的病例中对原始细胞进行染色;MB1、L26、UCHL1、4KB5和DAKO-M1在20%至50%的病例中染色;抗Leu-7和抗VIII因子相关抗原在不到20%的病例中染色。(3)在大多数病例中,许多T淋巴细胞、少量至中等数量的B淋巴细胞以及少数Leu-7阳性淋巴细胞与原始细胞相互混杂。在某些病例中,尤其是仅一小部分原始细胞被免疫染色的情况下,几乎不可能将肿瘤间质反应中的淋巴细胞与小原始细胞区分开来。因此,AML在环钻活检标本中表现出异质性免疫表型。在此类标本中对该疾病进行免疫组织学诊断可能极其困难。由于用通常用于定义B细胞、T细胞或其肿瘤衍生物的一种或多种抗体对原始细胞进行染色并不罕见,很容易误诊为高级别恶性非霍奇金淋巴瘤。这些发现还表明,同时表达髓系和淋巴细胞标志物的混合型(杂交型)急性白血病可能比普遍认识到的更为常见。